Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-1
SponsorBoston Children's Hospital

About this trial

The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants with lung disease around discharge from the neonatal intensive care unit to home. This study looks to evaluate implementation of the recommendations at Boston Children's Hospital and referring NICU's (Beth Israel Deaconess Medical Center and Brigham and Women's Hospital). Specifically, the research team will be looking at follow-up rates, healthcare utilization, and parental satisfaction/feedback with implementation of these guidelines.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Preterm infants born <32 weeks with at least mild BPD, defined as 28 days of respiratory support after birth.

Efforts will be made to include a mix of infants with mild, moderate, and severe BPD, including infants discharged on oxygen.

Disqualifiers

Discharge to a location other than home.

Infants with other congenital disease (cardiac, genetic, neurological) thought to contribute significantly to their respiratory disease.

Trial population

This will be an implementation study, measuring outcomes 3 months prior and 3 months after enactment of a discharge bundle for preterm infants with BPD at local NICUs (Brigham and Women's Hospital, Beth Israel Deaconess Medical Center) who will be followed by Boston Children's Hospital.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

50 Participants
are grouped into 2 trial groups
Group A: Pre-Guideline Implementation
Group B: Post-Guideline Implementation

Trial outcomes

Primary outcomes

1

Healthcare Utilization

Review of emergency encounters, urgent care visits, and hospital readmissions in the first 6 months after NICU discharge.

Time frame
8 months

Secondary outcomes

1

Rates of pulmonary follow-up and use of telemedicine in follow-up

Review of medical record

Time frame
8 months
2

Completion of recommended evaluations and testing

Review of medical record

Time frame
8 months
3

Medication use

Review of medical record

Time frame
8 months
4

Home oxygen use

Review of medical record

Time frame
8 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Boston Children's Hospital

Lead sponsor

Beth Israel Deaconess Medical Center

Collaborator

Brigham and Women's Hospital

Collaborator